CMS Will Use Medicare Advantage Data For Hospital Price Transparency Rule Opposed By Industry
Lobby group AdvaMed says hospital procedure price reporting threatens a competitive market
Executive Summary
The US Medicare agency wants hospitals to report prices for common hospital procedures based on median Medicare Advantage and other rates in a proposal that the medtech industry believes is anticompetitive.
You may also be interested in...
CMS Sets Insurers’ Deadlines To Comply With Final Health Care Price Transparency Rule
A final Medicare agency rule requiring insurers to reveal coverage prices for device-related procedures and tests will let consumers shop health services.
CMS Hospital Price Transparency Rule To Begin Public Reveal Of Device-Related Procedure Prices, Test Costs In 2021
The US Medicare agency on 15 November released a final cost transparency rule calling on hospitals to detail their standard “shoppable services” charges for X-rays, advanced imaging, laboratory tests and an array of other device-related procedures, beginning on 1 January 2021. Meanwhile, an accompanying proposed rule released by the CMS on the same day would require insurance health plans to provide to participants and beneficiaries the insurers’ negotiated rates for all covered health-care items and services.
Device-Related Procedure Costs To Be Revealed Under CMS Proposed Payment Rule
US hospitals would have to reveal on a public website their standard charges and insurer-negotiated prices for a long list of device-related procedures, advanced imaging scans, and lab tests under a proposed Centers for Medicare and Medicaid Services rule released on 29 July.